Trial Profile
An Open-Label, Multiple-Dosing, and Crossover Study to Evaluate the Pharmacokinetic Drug Interaction After Oral Concurrent Administration of Fimasartan and Amlodipine in Healthy Male Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Dec 2009
Price :
$35
*
At a glance
- Drugs Fimasartan (Primary) ; Amlodipine
- Indications Angina pectoris; Hypertension
- Focus Pharmacokinetics
- 09 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Oct 2009 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
- 15 Jul 2009 New trial record